12 July 2023
Preliminary studies show that psilocybin, a compound in magic mushrooms, reduces pain in people with chronic Lyme disease, fibromyalgia and migraines. But without effective control groups the evidence is far from conclusive
11 July 2023
Taking small amounts of the psychedelic substance LSD led to people sleeping for longer than when they took a placebo, but why this benefit only occurred the night after they microdosed is unclear
28 June 2023
Senior religious figures from a diverse range of faiths took psilocybin as part of a study on how people's worldviews influence their psychedelic experiences. Many said they felt the divine
28 April 2023
Computer simulations of a human brain under the influence of LSD show that entropy increases the most in regions responsible for processing vision and integrating sensory information
7 December 2022
Colorado has become the second US state to legalise psychedelic drugs for medicinal uses, but psychedelics research lags far behind studies on other drugs
17 November 2022
In adult mice, psychedelic drugs including LSD, ketamine and psilocybin have been shown to reopen the brain to a critical window for social learning usually only seen in adolescents
10 November 2021
Promising results from a psilocybin trial suggest that psychedelic therapies for depression could help some – but not all – people who don't respond to conventional antidepressants
3 March 2021
Some people find that taking small doses of psychedelic drugs can sharpen awareness or improve their mood, but these benefits may happen simply because people believe they will
12 June 2018
LSD and other members of the psychedelic family make neurons grow more branches, potentially explaining how they might treat depression
